Sign up to save your podcastsEmail addressPasswordRegisterOrContinue with GoogleAlready have an account? Log in here.
An AI-generated, human-curated podcast for brief discussions of US court decisions on Intellectual Property topics.... more
FAQs about Condensed IP:How many episodes does Condensed IP have?The podcast currently has 115 episodes available.
July 21, 2025Top Brand v. Cozy Comfort (Fed. Cir., July 17, 2025) 2024-2191This Federal Circuit opinion concerns an appeal of a patent and trademark infringement case between Top Brand LLC and Cozy Comfort Company LLC. Cozy Comfort had previously won a jury verdict claiming that Top Brand infringed on its design patent for an oversized hooded sweatshirt and its trademarks for "THE COMFY" wearable blankets. The appellate court reversed the lower court's decision, finding that Top Brand was not liable for design patent infringement because Cozy Comfort had surrendered certain design features during the patent application process, and these features were present in Top Brand's products. Additionally, the court concluded there was insufficient evidence to support trademark infringement, as the term "Comfy" was used descriptively by Top Brand and instances of actual consumer confusion were deemed minimal. As a result, the jury's awards for damages were overturned.This podcast is for entertainment purposes only and does not create an attorney-client relationship. The AI-generated hosts are not attorneys and are not providing legal advice. The choice of a lawyer is an important decision and should not be based solely upon advertisements....more14minPlay
July 21, 2025Shockwave Medical vs. Cardiovascular Systems (Fed. Cir., July 14, 2025) 2023-1864This opinion from the United States Court of Appeals for the Federal Circuit, dated July 14, 2025, concerns a patent dispute between Shockwave Medical, Inc. and Cardiovascular Systems, Inc. The case involves an inter partes review (IPR) of U.S. Patent No. 8,956,371, which covers a shockwave balloon catheter system for treating atherosclerosis. The core issue revolves around the patentability of claims within Shockwave's patent, specifically whether certain claims were obvious based on prior art. The court ultimately affirms the Board's finding that most of Shockwave's claims were unpatentable, while reversing the Board's decision regarding claim 5, deeming it also unpatentable. The opinion also addresses CSI's standing to bring the cross-appeal and clarifies the permissible use of applicant-admitted prior art (AAPA) in IPR proceedings.This podcast is for entertainment purposes only and does not create an attorney-client relationship. The AI-generated hosts are not attorneys and are not providing legal advice. The choice of a lawyer is an important decision and should not be based solely upon advertisements....more14minPlay
July 15, 2025Egenera v. Cisco (Fed. Cir., July 7, 2025) 2023-1428This decision concerns an appeal by Egenera, Inc. against Cisco Systems, Inc. before the United States Court of Appeals for the Federal Circuit. Egenera, the plaintiff-appellant, alleged that Cisco's Unified Computing System (UCS) infringed upon claims of its U.S. Patent No. 7,231,430. The appeal addresses the lower court's grant of summary judgment of non-infringement for claims 1 and 5, and its denial of Egenera's post-trial motions regarding claims 3 and 7 after a jury found no infringement. The court ultimately affirmed the district court's decisions, finding no errors in its handling of the claims or its procedural rulings.This podcast is for entertainment purposes only and does not create an attorney-client relationship. The AI-generated hosts are not attorneys and are not providing legal advice. The choice of a lawyer is an important decision and should not be based solely upon advertisements....more18minPlay
July 03, 2025Eye Therapies v. Slayback Pharma (Fed. Cir., June 30, 2025) 2023-2173This episode concerns an appeal before the United States Court of Appeals for the Federal Circuit, focusing on a patent dispute between Eye Therapies, LLC, and Slayback Pharma, LLC. The core of the appeal revolves around the interpretation of a patent claim for a method of reducing eye redness using brimonidine, specifically the phrase "consisting essentially of." Eye Therapies challenged a prior decision by the Patent Trial and Appeal Board (Board), which had deemed their patent unpatentable, arguing the Board misinterpreted this key phrase to allow for other active ingredients. The Federal Circuit reversed the Board's claim construction, ruling that the phrase, in this specific patent's context, excludes additional active ingredients, and remanded the case for further proceedings based on this revised interpretation.This podcast is for entertainment purposes only and does not create an attorney-client relationship. The AI-generated hosts are not attorneys and are not providing legal advice. The choice of a lawyer is an important decision and should not be based solely upon advertisements....more12minPlay
June 18, 2025OPTIS v. Apple (Fed. Cir., June 16, 2025) 2022-1904This opinion concerns an appeal in the case of Optis Cellular Technology, LLC v. Apple Inc., heard by the United States Court of Appeals for the Federal Circuit. The core of the dispute involves Optis's claims that Apple infringed on five of its standard-essential patents (SEPs) related to LTE technology, used in iPhones, iPads, and Watches. The court vacated earlier judgments on infringement and damages, mandating a new trial due to a non-unanimous jury verdict on infringement and the improper inclusion of an Apple-Qualcomm settlement agreement as evidence for damages. Additionally, the court reversed previous rulings regarding the patent eligibility of certain claims and the interpretation of another claim, while affirming a different claim construction, ultimately remanding the case for further proceedings.This podcast is for entertainment purposes only and does not create an attorney-client relationship. The AI-generated hosts are not attorneys and are not providing legal advice. The choice of a lawyer is an important decision and should not be based solely upon advertisements....more12minPlay
June 17, 2025Ancora v. Roku (Fed. Cir., June 16, 2025) 2023-1674This opinion from the United States Court of Appeals for the Federal Circuit details an appeal involving Ancora Technologies, Inc. against Roku, Inc., VIZIO, Inc., and Nintendo Co., Ltd. The core of the dispute revolves around the patentability of Ancora's U.S. Patent No. 6,411,941, which concerns software for restricting unauthorized use of licensed programs. Specifically, the court reviews the Patent Trial and Appeal Board's decision that claims of the patent were unpatentable due to obviousness, particularly focusing on the interpretation of the term "agent" within the patent's claims and the nexus analysis of objective evidence of nonobviousness, such as licensing agreements. The Court of Appeals ultimately vacated and remanded the Board's decision, finding errors in how the Board applied precedent regarding the nexus of license evidence to nonobviousness.This podcast is for entertainment purposes only and does not create an attorney-client relationship. The AI-generated hosts are not attorneys and are not providing legal advice. The choice of a lawyer is an important decision and should not be based solely upon advertisements....more17minPlay
June 15, 2025Agilent v Synthego (Fed. Cir., June 11, 2025) 2023-2186This Federal Circuit opinion concerns an appeal from Agilent Technologies, Inc. against Synthego Corp., concerning the patentability of gene-editing technology related to CRISPR-Cas systems. Agilent appealed decisions by the Patent Trial and Appeal Board, which found all claims of Agilent's U.S. Patent Nos. 10,337,001 and 10,900,034 unpatentable due to anticipation or obviousness based on prior art. The core of the dispute revolves around whether earlier works, particularly "Pioneer Hi-Bred," "Threlfall," and "Deleavey," expressly disclosed or enabled the chemically modified guide RNAs (gRNAs) and their functionality as claimed by Agilent. The court ultimately affirmed the Board's findings, concluding that substantial evidence supported the prior art's anticipatory disclosures and enablement, as well as the obviousness of certain claims.This podcast is for entertainment purposes only and does not create an attorney-client relationship. The AI-generated hosts are not attorneys and are not providing legal advice. The choice of a lawyer is an important decision and should not be based solely upon advertisements....more19minPlay
June 14, 2025USAA v. PNC Bank (Fed. Cir., June 12, 2025) 2023-1639This is a Federal Circuit opinion regarding a patent dispute between United Services Automobile Association (USAA) and PNC Bank N.A., heard by the United States Court of Appeals for the Federal Circuit. The core of the appeal concerns the patent eligibility of USAA's "Digital Camera Processing System" patent, specifically U.S. Patent No. 10,769,598, U.S. Patent No. 10,402,638, and U.S. Patent No. 9,224,136, under 35 U.S.C. § 101. The court applied the two-step Alice test to determine if the patent claims were directed to an abstract idea and, if so, whether they contained an inventive concept. Ultimately, the court reversed the district court's summary judgment in favor of USAA, concluding that the asserted claim from the ’638 patent was directed to an abstract idea without an inventive concept, thus deeming it unpatentable.This podcast is for entertainment purposes only and does not create an attorney-client relationship. The AI-generated hosts are not attorneys and are not providing legal advice. The choice of a lawyer is an important decision and should not be based solely upon advertisements....more12minPlay
June 13, 2025Fraunhofer-Gesellschaft v. Sirius XM Radio (Fed. Cir., June 9, 2025) 2023-2267This is an opinion from the United States Court of Appeals for the Federal Circuit concerning a patent infringement case between Fraunhofer-Gesellschaft and Sirius XM Radio Inc. The core issue revolves around equitable estoppel, a legal defense where a party is prevented from asserting a claim due to their misleading conduct and another party's detrimental reliance on that conduct. The court reversed the district court's summary judgment in favor of Sirius XM, finding that while Fraunhofer's five-year silence constituted misleading conduct, there was a dispute of material fact regarding Sirius XM's reliance on that silence when making business decisions about its satellite radio systems. The case will return to the district court for further proceedings to resolve this factual dispute.This podcast is for entertainment purposes only and does not create an attorney-client relationship. The AI-generated hosts are not attorneys and are not providing legal advice. The choice of a lawyer is an important decision and should not be based solely upon advertisements....more14minPlay
June 12, 2025Dolby Laboratories Licensing v. Unified Patents (Fed. Cir., June 5, 2025) 2023-2110This Federal Circuit opinion relates to an appeal from Dolby Laboratories Licensing Corporation (Dolby) against Unified Patents, LLC (Unified) regarding a patent dispute. The core issue revolves around Dolby's lack of standing to appeal the Patent Trial and Appeal Board's (Board) decision, as determined by the U.S. Court of Appeals for the Federal Circuit. Dolby attempted to argue standing based on a statutory right to appeal as a "dissatisfied" party, a supposed informational right to know all real parties in interest (RPIs) in the patent review, and various speculative harms, but the court rejected all these arguments. The court emphasized that a statutory right to appeal does not override the constitutional requirement for Article III standing, which necessitates a concrete injury-in-fact. Ultimately, the appeal was dismissed because Dolby failed to demonstrate a sufficient injury.This podcast is for entertainment purposes only and does not create an attorney-client relationship. The AI-generated hosts are not attorneys and are not providing legal advice. The choice of a lawyer is an important decision and should not be based solely upon advertisements....more14minPlay
FAQs about Condensed IP:How many episodes does Condensed IP have?The podcast currently has 115 episodes available.